Inferior Vena Cava Filter Market Growth Factors:
Inferior Vena cava (IVC) Filters are employed to prevent the blood clots from reaching the lungs and thereby are employed in preventing pulmonary emboli. They are implanted only in case of high risk when anticoagulant therapy cannot be used. As the awareness towards the advancements in medical research is increasing the demand for improved medical imaging and minimally invasive medical procedures are gradually increasing, this is in turn driving the IVC Filter market. MI (Minimally Invasive) procedures decrease the possibility of blood vessel infection and are more effective. Growing number of cardiovascular diseases is also a crucial growth factor for the IVC Filter market. By 2030, the number of deaths caused by cardiovascular diseases is expected to reach 24 million annually.
Detailed Segmentation of the Inferior Vena Cava Filter Market:
By Application:
By Product Type
By Material:
By End User
Geographical Segmentation of the Market:
Segmentation Growth Analysis:
IVC filters can be implanted either temporarily or permanently based on the patient's requirement. Among the End Users segment, Hospitals are dominating the market presence as the surgeries required for cardiovascular diseases are constantly swelling.
Regional Analysis of the Market:
North America is dominating the global market closely followed by Europe. The high geriatric population and snowballing cases of cardiovascular diseases are the primary growth factors for the Western markets. Growing patient awareness towards the treatments available for cardiovascular diseases makes the potential for market expansion in Asia huge.
Top Major Companies mentioned in this market:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Application
5.1.1 Introduction
5.1.2 Treatment Venous Thromboembolism
5.1.3 Prevent Pulmonary Embolism
5.1.4 Y-o-Y Growth Analysis, By Application
5.1.5 Market Attractiveness Analysis, By Application
5.1.6 Market Share Analysis, By Application
5.2 Product
5.2.1 Introduction
5.2.2 Retrievable IVC Filter
5.2.3 Permanent IVC Filter
5.2.4 Y-o-Y Growth Analysis, By Product
5.2.5 Market Attractiveness Analysis, By Product
5.2.6 Market Share Analysis, By Product
5.3 Material
5.3.1 Introduction
5.3.2 Non-Ferromagnetic material
5.3.3 Ferromagnetic material
5.3.4 Y-o-Y Growth Analysis, By Material
5.3.5 Market Attractiveness Analysis, By Material
5.3.6 Market Share Analysis, By Material
5.4 End User
5.4.1 Introduction
5.4.2 Ambulatory Surgical Centres
5.4.3 Hospitals
5.4.4 Other End Users
5.4.5 Y-o-Y Growth Analysis, By End User
5.4.6 Market Attractiveness Analysis, By End User
5.4.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Application
6.1.3.3 By Product
6.1.3.4 By Material
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Application
6.1.4.3 By Product
6.1.4.4 By Material
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Application
6.1.5.3 By Product
6.1.5.4 By Material
6.1.5.5 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 C.R.Bard
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Boston Scientific
8.3 Cardinal Health
8.4 Cook Medical
8.5 B.Braun
8.6 ALN
8.7 Braile Biomedica
8.8 Philips Volcano
8.9 Argon Medical Devices
8.10 VENITI
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
